The expression of efflux and uptake transporters are regulated by statins in Caco-2 and HepG2 cells

被引：0
|
作者：
Alice Cristina Rodrigues
Rui Curi
Fabiana Dalla Vecchia Genvigir
Mario Hiroyuki Hirata
Rosario Dominguez Crespo Hirata
机构：
[1] Faculty of Pharmaceutical Sciences,Department of Clinical and Toxicological Analysis
[2] University of Sao Paulo,Department of Physiology and Biophysics
[3] Institute of Biomedical Sciences,undefined
[4] University of Sao Paulo,undefined
来源：
Acta Pharmacologica Sinica | 2009年 / 30卷
关键词：
simvastatin; atorvastatin; Caco-2 cells; HepG2 cells; drug transporters;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：956 / 964
页数：8
相关论文
共 47 条
  • [21] Effects of three different formulae of Gamisoyosan on lipid accumulation induced by oleic acid in HepG2 cells
    Go, Hiroe
    Ryuk, Jin Ah
    Hwang, Joo Tae
    Ko, Byoung Seob
    INTEGRATIVE MEDICINE RESEARCH, 2017, 6 (04) : 395 - 403
  • [22] Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells
    Rodrigues, Alice Cristina
    Curi, Rui
    Hirata, Mario Hiroyuki
    Crespo Hirata, Rosario Dominguez
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 37 (3-4) : 486 - 491
  • [23] Atorvastatin induces mitochondrial dysfunction and cell apoptosis in HepG2 cells via inhibition of the Nrf2 pathway
    Li, Li-Zhong
    Zhao, Zeng-Ming
    Zhang, Li
    He, Jun
    Zhang, Ting-Fen
    Guo, Jia-Bin
    Yu, Lin
    Zhao, Jun
    Yuan, Xiao-Yan
    Peng, Shuang-Qing
    JOURNAL OF APPLIED TOXICOLOGY, 2019, 39 (10) : 1394 - 1404
  • [24] CYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 Cells
    Yang, Weihong
    Zhao, Huan
    Dou, Yaojie
    Wang, Pei
    Chang, Qi
    Qiao, Xiaomeng
    Wang, Xiaofei
    Xu, Chen
    Zhang, Zhe
    Zhang, Lirong
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (04) : 492 - 498
  • [25] Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells
    Funatsu, T
    Suzuki, K
    Goto, M
    Arai, Y
    Kakuta, H
    Tanaka, H
    Yasuda, S
    Ida, M
    Nishijima, S
    Miyata, K
    ATHEROSCLEROSIS, 2001, 157 (01) : 107 - 115
  • [26] Atorvastatin induces MicroRNA-145 expression in HEPG2 cells via regulation of the PI3K/AKT signalling pathway
    Docrat, Taskeen Fathima
    Nagiah, Savania
    Krishnan, Anand
    Naidoo, Dhaneshree B.
    Chuturgoon, Anil A.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 287 : 32 - 40
  • [27] Effect of sorafenib and simvastatin treatment on apoptosis of HepG2 cells and on the relevant proteins of the hippo signaling pathway
    Zou, Fang
    Jiang, Lili
    Wei, Honglong
    Dong, Chenchen
    Wang, Xin
    Li, Jie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (03): : 1423 - 1430
  • [28] Effect of FR194738, a potent inhibitor of squalene epoxidase, on cholesterol metabolism in HepG2 cells
    Sawada, M
    Matsuo, M
    Hagihara, H
    Tenda, N
    Nagayoshi, A
    Okumura, H
    Washizuka, K
    Seki, J
    Goto, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 431 (01) : 11 - 16
  • [29] Atorvastatin-TPGS-PLGA Nanoparticles Cytotoxicity Augmentation Against Liver Cancer HepG2 cells
    Alfaifi, Mohammad Y.
    Shati, Ali A.
    Alshehri, Mohammed Ali
    Elbehairi, Serag Eldin, I
    Fahmy, Usama A.
    Alshehri, Ohoud Yahya
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2020, 16 (02) : 79 - 86
  • [30] Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin
    Wilcox, LJ
    Barrett, PHR
    Huff, MW
    JOURNAL OF LIPID RESEARCH, 1999, 40 (06) : 1078 - 1089
12345